相关产品推荐更多 >

CD1c (BDCA-1) Antibody, anti-human, FITC, 30 tests in 60 µL
询价
CD94 Antibody, anti-mouse, FITC, 30 µg in 1 mL
询价
CD106 (VCAM-1) Antibody, anti-human, PerCP-Vio® 700, REAfinity™, 100 tests in 200 µL
询价
CD62P Antibody, anti-human, Vio® Bright B515, REAfinity™, 30 tests in 60 µL
询价
HLA-A2 Antibody, anti-human, FITC, REAlease®, 100 tests in 200 µL
询价
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原:
CD57
- 形态:
Reagents are supplied in buffer containing stabilizer and 0.05% sodium azide.
- 保存条件:
避光,4-8℃
- 克隆性:
REAL352
- 标记物:
Vio B515
- 适应物种:
human
- 保质期:
24个月
- 供应商:
Miltenyi biotec
- 宿主:
cell line
- 应用范围:
MICS (MACSima Imaging Cyclic Staining), Immunofluorescence, Immunohistochemistry
- 抗体英文名:
CD57 Antibody, anti-human, REAdye_lease™
- 抗体名:
CD57 Antibody, anti-human, REAdye_lease™
- 规格:
200 µL
Detection of CD57+ cellsClone REAL352 is an antibody fragment derived from the full CD57 antibody molecule. It displays no binding to Fc receptors. The recombinantly engineered antibody fragments are multimerized to form the REAdye_lease Complex to bind markers with high avidity. | Clone REAL352 recognizes the human CD57 antigen. CD57, also known as HNK-1 or Leu-7, is an antigenic oligosaccharide moiety detected on extracellular proteins of certain cell types. In blood, CD57 is found on 15–20% of mononuclear cells, including subsets of NK and T cells, but not on erythrocytes, monocytes, granulocytes, or platelets. CD57 expression can be also found on a variety of neural cell types. CD57 has been shown to be expressed on late stage effector CD8+ T cells. The frequency of CD57+ T lymphocytes is raised in a variety of diseases. CD57 expression is also increased on chronically activated CD8+ T cells in persistent viral infections, such as HIV. CD57 is a helpful marker to differentiate between Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) and T-cell/histiocyte-rich B-cell lymphoma (T/HRBCL). | For removal of REAdye_lease fluorochromes for optional relabeling with different fluorochrome-conjugated REAdye_lease antibodies use the REAlease Support Kit (130-120-675).
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验该产品被引用文献
Brenchley, J. M. et al. (2003) Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells. Blood 101: 2711–2720. | Boudová, L. et al. (2003) Nodular lymphocyte-predominant Hodgkin lymphoma with nodules resembling T-cell/histiocyte-rich B-cell lymphoma: differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma. Blood 102 (10): 3753–3758. | Muntasell, A. et al. (2019) High Numbers of Circulating CD57(+) NK Cells Associate with Resistance to HER2-Specific Therapeutic Antibodies in HER2(+) Primary Breast Cancer. Cancer Immunol Res. 7 (8): 1280–1292. | Lian, J. et al. (2020) Immunosenescence: a key player in cancer development. J Hematol Oncol. 13 (1): 151.
技术资料暂无技术资料 索取技术资料
文献支持
CD57 Antibody, anti-human, Vio® B515, REAdye_lease™, 200 µL
询价





